MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Unsuitable for MCA as requires buccal administration, rather than swallowing.

Provenance

This compatibility recommendation is derived from Buccastem M 3mg tablets (Alliance Pharmaceuticals Ltd).

Stability Notes

Protect from light and store in airtight containers.

Provenance

This compatibility recommendation is derived from Budenofalk 3mg gastro-resistant capsules (Dr. Falk Pharma UK Ltd).

Stability Notes

Protect from light and store in airtight containers. SPC states store in original packaging, which contains a desiccant. Company have stability studies that demonstrate stability in open storage for 3 months.

Provenance

This compatibility recommendation is derived from Entocort CR 3mg capsules (Tillotts Pharma UK Ltd).

Stability Notes

Protect from light and store in airtight containers. SPC states store in original packaging, which contains a desiccant. Company have stability studies that demonstrate stability in open storage for 3 months.

Provenance

This compatibility recommendation is derived from Entocort CR 3mg capsules (Tillotts Pharma UK Ltd).

Stability Notes

Protect from light and store in airtight containers. SPC states store in original packaging, which contains a desiccant. Company have stability studies that demonstrate stability in open storage for 3 months.

Provenance

This compatibility recommendation is derived from Entocort CR 3mg capsules (Tillotts Pharma UK Ltd).

Stability Notes

Protect from light and store in airtight containers. SPC states store in original packaging, which contains a desiccant. Company have stability studies that demonstrate stability in open storage for 3 months.

Provenance

This compatibility recommendation is derived from Entocort CR 3mg capsules (Tillotts Pharma UK Ltd).

Stability Notes

Protect from light. Store in airtight containers. Bumetanide is photosensitive and will discolour when exposed to light.

Provenance

This compatibility recommendation is derived from Bumetanide 1mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in airtight containers. Bumetanide is photosensitive and will discolour when exposed to light.

Provenance

This compatibility recommendation is derived from Bumetanide 1mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in airtight containers. Bumetanide is photosensitive and will discolour when exposed to light.

Provenance

This compatibility recommendation is derived from Bumetanide 1mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in airtight containers. Bumetanide is photosensitive and will discolour when exposed to light.

Provenance

This compatibility recommendation is derived from Bumetanide 1mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in airtight containers. Bumetanide is photosensitive and will discolour when exposed to light.

Provenance

This compatibility recommendation is derived from Bumetanide 1mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in airtight containers. Bumetanide is photosensitive and will discolour when exposed to light.

Provenance

This compatibility recommendation is derived from Bumetanide 1mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in airtight containers. Bumetanide is photosensitive and will discolour when exposed to light.

Provenance

This compatibility recommendation is derived from Bumetanide 1mg tablets (Teva UK Ltd).

Stability Notes

Protect from light. Store in airtight containers. Bumetanide is photosensitive and will discolour when exposed to light.

Provenance

This compatibility recommendation is derived from Bumetanide 1mg tablets (Teva UK Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.